BIOCRYST PHARMACEUTICALS INC Development Agreements

17 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
AL
2021
the preclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO(berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2022
the preclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO(berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2022
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
DE
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
NY
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
AL
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
DE
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
DE
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2021
Amendment #9 to the Agreement between BioCryst Pharmaceuticals, Inc. and the Biomedical Advanced Research and Development Authority within the U.S. Department of Health and Human...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2018
Name TitleWilliam P. Sheridan, M.D. Chief Medical Officer, Principal InvestigatorElliott Berger, Ph.D. Sr. Vice President, Regulatory AffairsWalter G. Gowan, Ph.D. Vice President...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2009
AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT 1. CONTRACT ID CODE PAGE OF PAGES 1 1 2. AMENDMENT/MODIFICATION NO: 3. EFFECTIVE DATE 4. REQUISITION/PURC 5. PROJECT NO. (If...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2008